Viatris Inc.: Pulmonary Disease, Chronic Obstructive trials

The registry lists 18 Pulmonary Disease, Chronic Obstructive studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 10 have results posted.

Phase 1 1Phase 2 9Phase 3 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT05046795Phase 3Results posted
• A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPDCompletedNCT03573817Phase 3Results posted
• Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPDCompletedNCT03095456Phase 3Results posted
• Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03064113Phase 2Results posted
• A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02518139Phase 3Results posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02512510Phase 3Results posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02459080Phase 3Results posted
• A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02109172Phase 2Results posted
• A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02040792Phase 2Results posted
• 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01704404Phase 2Results posted
• TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male SubjectsCompletedNCT02772159Phase 1
• A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01168310Phase 2
• A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01113593Phase 2
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00774761Phase 2
• Study in Subjects Greater Than 40 Years of Age With COPDCompletedNCT00507234Phase 3
• A Crossover Study in the Treatment of Patients With COPDCompletedNCT00462540Phase 3
• A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00403286Phase 2
• Study in Patients With COPDCompletedNCT00215423Phase 2